Stocksigma LogoStocksigma Logo

Genpharmasec Confirms Nil Deviation in Rights Issue Proceeds Utilization for Sep'26 Quarter

Genpharmasec Limited reported zero deviation or variation in utilizing proceeds from its Rights Issue (allotted 21st Feb'24) for the quarter ended 30th

Genpharmasec Confirms Nil Deviation in Rights Issue Proceeds Utilization for Sep'26 Quarter

Genpharmasec Ltd 路 Others (Uncategorized) 路 03 Nov 2026, 11:16 pm

Genpharmasec Confirms Nil Deviation in Rights Issue Proceeds Utilization for Sep'26 Quarter Genpharmasec Limited reported zero deviation or variation in utilizing proceeds from its Rights Issue (allotted 21st Feb'24) for the quarter ended 30th Sep'26. Out of Rs. 4,845.05 Lakhs total raised, key allocations include Rs. 1,650.00 Lakhs fully utilized for working capital, Rs. 1,443.58 Lakhs fully utilized to acquire shares in Derren Healthcare Private Limited, Rs. 1,138.47 Lakhs for general corporate purposes, and Rs. 25.00 Lakhs for issue expenses. Additionally, Rs. 289.00 Lakhs has been utilized toward debt repayment out of an allocated Rs. 588.00 Lakhs.

Original exchange filing (PDF)

More announcements from Genpharmasec Ltd

All Genpharmasec Ltd announcements